Trichosporon beigelii is an uncommon cause of sepsis in low-birth-weig
ht infants. We present two cases of neonatal trichosporonosis and two
cases of neonatal trichosporon colonization to familiarize neonatologi
sts with this entity and to discuss management considerations. A 23-we
ek-gestation male developed clinical evidence of sepsis on day 10 and
was found to have ''yeast'' growing in a blood culture on day 12. Desp
ite receiving amphotericin B, he expired within 2 days, at which time
the organism was identified as T. beigelii. A 23-week-gestation female
developed fungal septicemia in the second week of life, while being t
reated for persistent bacterial sepsis. Candida albicans grew from blo
od culture, while T. beigelii grew from suprapubic urine, tracheal asp
irate, and umbilical catheter tip cultures. She died 2 days later desp
ite therapy with amphotericin B, at which time the fungal isolates wer
e correctly identified. Two other infants were found to have colonizat
ion of central vascular catheters, without evidence of invasive diseas
e. Trichosporon infections in neonates have been almost uniformly fata
l. Most strains of T. beigelii are relatively resistant to amphoterici
n B and may be confused with Candida sp. on initial culture examinatio
ns. Therefore, delays in appropriate treatment may occur. We discuss t
reatment options, including alternative antifungal drugs, as well as p
ossibilities for combination therapy.